BD, CerTest Biotec announced Emergency Use Authorization for Mpox diagnostic test
On Jan. 9, 2023, BD (Becton, Dickinson) and CerTest Biotec have announced Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for a molecular polymerase chain reaction assay for Mpox virus detection.
The BD MAXル System is a fully integrated, automated platform that performs nucleic acid extraction and real-time PCR providing results for up to 24 samples across multiple syndromes in less than three hours.
Tags:
Source: Becton, Dickinson and Company
Credit: